Literature DB >> 16788941

The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency.

Mehmet Ali Gulcelik1, Nese Ersoz Gulcelik, Soykan Dinc, Bekir Kuru, Mithat Camlibel, Haluk Alagol.   

Abstract

BACKGROUND: The incidence of hyperthyroidism among thyroid malignancy varies greatly depending on the geographical area and iodine intake. The aim of the study was to evaluate the association of hyperthyroidism and thyroid cancer (TC) in an iodine deficient area. PATIENTS AND METHODS: Medical records of 422 patients who underwent operation for TC between 1992 and 2000 in Ankara Oncology Hospital were reviewed. The characteristics of TC patients with hyperthyroidism were analyzed in respect to gender, age, histopathological type, thyroid function status, tumor size, extrathyroidal invasion, local recurrences, distant metastasis, AMES and MACIS scoring.
RESULTS: In the present patient series, among 422 patients with TC, hyperthyroidism was found in 12 patients (2.8%). None of the patients had Graves' disease. Of 12 patients with hyperthyroidism, 9 patients had papillary carcinoma, 1 patient had follicular carcinoma and 2 patients had follicular variant of papillary carcinoma. The tumor was in the active nodule in 5 patients.
CONCLUSION: The existence of hyperthyroidism among patients with differentiated TC is a clinical entity. Patients with hyperthyroidism and nodules require a careful approach in order to establish or exclude the possibility of TC especially in formerly iodine deficient areas. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788941     DOI: 10.1002/jso.20508

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Decreased gene expression of KACh and KATP channels in hyperthyroid rabbit atria.

Authors:  Feng Zhang; Guang Hai Zhou; Qi An; Jie Yang; Yu Hao Wang; Jia Quan Zhu; Song Nan Jin; Jin Fu Wen
Journal:  Int J Clin Exp Pathol       Date:  2022-03-15

2.  MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel.

Authors:  Ji Hye Hwang; Seok Yong Kang; An Na Kang; Hyo Won Jung; Chul Jung; Jin-Ho Jeong; Yong-Ki Park
Journal:  BMC Complement Altern Med       Date:  2017-12-15       Impact factor: 3.659

3.  Antioxidant and Protective Effects of Bupleurum falcatum on the L-Thyroxine-Induced Hyperthyroidism in Rats.

Authors:  Seong-Mo Kim; Sang-Chan Kim; In-Kwon Chung; Woo-Hyun Cheon; Sae-Kwang Ku
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-25       Impact factor: 2.629

4.  Alterations in expression of senescence marker protein-30 gene by 3,3',5-triiodo-L-thyronine (T3).

Authors:  Pranati Sar; Bandita Rath; Umakanta Subudhi; Gagan Bihari Nityananda Chainy; Prakash Chandra Supakar
Journal:  Mol Cell Biochem       Date:  2007-04-11       Impact factor: 3.842

5.  Efficacy comparison of the anterior low small incision and the traditional incision for treatment of thyroid adenoma.

Authors:  Zhen Zhang
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

6.  A case report of hyperfunctioning metastatic thyroid cancer and rare I-131 avid liver metastasis.

Authors:  Anchisa Kunawudhi; Chetsadaporn Promteangtrong; Chanisa Chotipanich
Journal:  Indian J Nucl Med       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.